Background: Brain radiotherapy is the usual remedy possibility for a number of mind metastases (BMs) from non-small cell lung most cancers (NSCLC), particularly in the absence of a driver mutation. However, the prognosis for such sufferers stays poor. Apatinib is a potent antiangiogenic compound directed on the vascular endothelial progress issue receptor-2 (VEGFR-2); nevertheless, to date, there are not any investigations of apatinib concurrent with mind radiotherapy for NSCLC sufferers with BMs.
We report a case of EGFR wild-type and ALK-negative lung adenocarcinoma affected person with a number of symptomatic BMs, who obtained apatinib along with mind radiation remedy. A positive oncologic consequence was achieved for each mind metastatic lesions and the first pulmonary tumor. Case Presentation: A 61-year-old feminine (by no means smoker) who initially offered with headache and dizziness was recognized with lung adenocarcinoma with a number of mind metastasis (cT2aN3M1b stage IV), and was unfavorable for EGFR and ALK.
The affected person refused to obtain chemotherapy and was solely amenable to mind radiotherapy and focused remedy. After approval from the institutional ethics committee, she underwent concurrent oral apatinib (500 mg/day) with complete mind radiation remedy (WBRT) (37.5Gy) with simultaneous in-field increase (49.5Gy) in 15 fractions with picture guided intensity-modulated radiotherapy.
Three weeks later, neurologic signs totally ceased and a partial response (PR) for the BMs with near-complete decision of peritumoral mind edema was achieved. Chest CT carried out on the identical time and confirmed shrinkage of the lung main with a PR.
The affected person suffered grade III oral mucositis one week after mind radiotherapy and refused additional apatinib. At 12 months after mind radiotherapy, the mind tumors remained properly managed. Conclusions: This is the primary identified documentation of a speedy medical response of apatinib concurrent with mind radiotherapy in a lung adenocarcinoma affected person with symptomatic a number of BMs. Apatinib mixed with mind radiotherapy could possibly be another remedy possibility for BMs from NSCLC, particularly for these with no driver mutation. Further medical trials are required to corroborate this discovery.

Pattern of Pediatric Supracondylar Fracture Operated at A Rural Teaching Hospital of Nepal: A Descriptive Cross-sectional Study.
Supracondylar fracture of humerus is likely one of the frequent pediatric fractures encountered in our every day medical observe. The goal of this examine is to decide the sample of supracondylar fracture operated at rural educating hospital of Jumla, Karnali Nepal.A descriptive cross sectional examine was carried out at Jumla, Karnali after Institutional Review Committee approval.
Operating room notes from 15 May 2017 to 16 November 2019 had been retrieved to collect the next data: sufferers tackle, age, intercourse, aspect, harm mechanism, displacement, neurovascular harm, concurrent accidents, preliminary administration by conventional bone setters, time between harm and surgical procedure, operative method.
NOD2 Antibody |
|||
1-CSB-PA015915GA01HU | Cusabio |
|
|
Description: A polyclonal antibody against NOD2. Recognizes NOD2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB |
|||
NOD2 Antibody |
|||
1-CSB-PA881021LA01HU | Cusabio |
|
|
Description: A polyclonal antibody against NOD2. Recognizes NOD2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200 |
|||
NOD2 Peptide |
|||
45-973P | ProSci | 0.1 mg | 405.6 EUR |
Description: (IN) CARD15 / NOD2 Peptide |
|||
NOD2 antibody |
|||
70R-18913 | Fitzgerald | 50 ul | 522 EUR |
Description: Rabbit polyclonal NOD2 antibody |
|||
NOD2 Antibody |
|||
37460-100ul | SAB | 100ul | 302.4 EUR |
NOD2 Antibody |
|||
24158-100ul | SAB | 100ul | 468 EUR |
NOD2 Antibody |
|||
24159-100ul | SAB | 100ul | 468 EUR |
Nod2 antibody |
|||
10R-6553 | Fitzgerald | 100 ug | 522 EUR |
Description: Rat monoclonal Nod2 antibody |
|||
NOD2 Antibody |
|||
2511-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: NOD2 Antibody: Apaf-1 and NOD1 are members of a new family, which are involved in the regulation of apoptosis and immune response. Each of them contains a caspase recruitment domain (CARD) and a nucleotide-binding oligomerization domain (NOD). A third member in this family was recently identified and designated NOD2. NOD2 interacts with RICK via a homophilic CARD-CARD interaction. NOD2 activates NF-κB, which is regulated by its carboxy-terminal leucine-rich repeat domain that acts as an intracellular receptor for components of bacteria. The variants of NOD2, either a frameshift or a missense, were associated with Crohn's disease that is a main type of chronic inflammatory bowel disease. |
|||
NOD2 Antibody |
|||
2511-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: NOD2 Antibody: Apaf-1 and NOD1 are members of a new family, which are involved in the regulation of apoptosis and immune response. Each of them contains a caspase recruitment domain (CARD) and a nucleotide-binding oligomerization domain (NOD). A third member in this family was recently identified and designated NOD2. NOD2 interacts with RICK via a homophilic CARD-CARD interaction. NOD2 activates NF-κB, which is regulated by its carboxy-terminal leucine-rich repeat domain that acts as an intracellular receptor for components of bacteria. The variants of NOD2, either a frameshift or a missense, were associated with Crohn's disease that is a main type of chronic inflammatory bowel disease. |
|||
NOD2 Peptide |
|||
2511P | ProSci | 0.05 mg | 197.7 EUR |
Description: (NT) NOD2 peptide |
|||
NOD2 Antibody |
|||
2513-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: NOD2 Antibody: Apaf-1 and NOD1 are members of a new family, which are involved in the regulation of apoptosis and immune response. Each of them contains a caspase recruitment domain (CARD) and a nucleotide-binding oligomerization domain (NOD). A third member in this family was recently identified and designated NOD2. NOD2 interacts with RICK via a homophilic CARD-CARD interaction. NOD2 activates NF-κB, which is regulated by its carboxy-terminal leucine-rich repeat domain that acts as an intracellular receptor for components of bacteria. The variants of NOD2, either a frameshift or a missense, were associated with Crohn's disease that is a main type of chronic inflammatory bowel disease. |
|||
NOD2 Antibody |
|||
2513-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: NOD2 Antibody: Apaf-1 and NOD1 are members of a new family, which are involved in the regulation of apoptosis and immune response. Each of them contains a caspase recruitment domain (CARD) and a nucleotide-binding oligomerization domain (NOD). A third member in this family was recently identified and designated NOD2. NOD2 interacts with RICK via a homophilic CARD-CARD interaction. NOD2 activates NF-κB, which is regulated by its carboxy-terminal leucine-rich repeat domain that acts as an intracellular receptor for components of bacteria. The variants of NOD2, either a frameshift or a missense, were associated with Crohn's disease that is a main type of chronic inflammatory bowel disease. |
|||
NOD2 Peptide |
|||
2513P | ProSci | 0.05 mg | 197.7 EUR |
Description: (CT) NOD2 peptide |
|||
anti-NOD2 |
|||
YF-PA27607 | Abfrontier | 50 ug | 435.6 EUR |
Description: Mouse polyclonal to NOD2 |
|||
NOD2 Antibody |
|||
R34436-100UG | NSJ Bioreagents | 100 ug | 399 EUR |
NOD2 Blocking Peptide |
|||
DF12125-BP | Affbiotech | 1mg | 234 EUR |
NOD2 Conjugated Antibody |
|||
C37460 | SAB | 100ul | 476.4 EUR |
NOD2 Rabbit pAb |
|||
A15992-100ul | Abclonal | 100 ul | 369.6 EUR |
NOD2 Rabbit pAb |
|||
A15992-200ul | Abclonal | 200 ul | 550.8 EUR |
NOD2 Rabbit pAb |
|||
A15992-20ul | Abclonal | 20 ul | 219.6 EUR |
NOD2 Rabbit pAb |
|||
A15992-50ul | Abclonal | 50 ul | 267.6 EUR |
Polyclonal NOD2 Antibody |
|||
APR06297G | Leading Biology | 0.1 mg | 790.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD2 . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal NOD2 Antibody |
|||
APR06298G | Leading Biology | 0.1 mg | 790.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD2 . This antibody is tested and proven to work in the following applications: |
|||
Anti-NOD2 antibody |
|||
PAab05781 | Lifescience Market | 100 ug | 494.4 EUR |
Anti-NOD2 antibody |
|||
STJ118451 | St John's Laboratory | 100 µl | 332.4 EUR |
Human NOD2 shRNA Plasmid |
|||
20-abx961935 | Abbexa |
|
|
NOD2 Antibody, HRP conjugated |
|||
1-CSB-PA881021LB01HU | Cusabio |
|
|
Description: A polyclonal antibody against NOD2. Recognizes NOD2 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
NOD2 Antibody, FITC conjugated |
|||
1-CSB-PA881021LC01HU | Cusabio |
|
|
Description: A polyclonal antibody against NOD2. Recognizes NOD2 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
NOD2 Antibody, Biotin conjugated |
|||
1-CSB-PA881021LD01HU | Cusabio |
|
|
Description: A polyclonal antibody against NOD2. Recognizes NOD2 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|||
Anti-NOD2 (Card15) Antibody |
|||
A00087 | BosterBio | 50 ul | 476.4 EUR |
Description: Rabbit Polyclonal NOD2 (Card15) Antibody. Validated in IP, IHC, WB and tested in Human. |
|||
Mouse Nod2 ELISA KIT |
|||
ELI-44123m | Lifescience Market | 96 Tests | 1038 EUR |
Bovine NOD2 ELISA KIT |
|||
ELI-22273b | Lifescience Market | 96 Tests | 1113.6 EUR |
Human NOD2 ELISA KIT |
|||
ELI-23582h | Lifescience Market | 96 Tests | 988.8 EUR |
NOD2 ELISA KIT|Human |
|||
EF001273 | Lifescience Market | 96 Tests | 826.8 EUR |
TLR2 & NOD2-Based Adjuvant |
|||
VAdv-Ly0016 | Creative Biolabs | 5 mg | 4016.4 EUR |
Description: A TLR2 & NOD2-based vaccine adjuvant. |
|||
NOD2 ELISA Kit (Mouse) (OKCA01740) |
|||
OKCA01740 | Aviva Systems Biology | 96 Wells | 1015.2 EUR |
Description: Description of target: Involved in gastrointestinal immunity. Upon stimulation by muramyl dipeptide (MDP), a fragment of bacterial peptidoglycan, binds the proximal adapter receptor-interacting RIPK2, which recruits ubiquitin ligases as XIAP, BIRC2, BIRC3 and the LUBAC complex, triggering activation of MAP kinases and activation of NF-kappa-B signaling. This in turn leads to the transcriptional activation of hundreds of genes involved in immune response (PubMed:22607974). Required for MDP-induced NLRP1-dependent CASP1 activation and IL1B release in macrophages (PubMed:18511561).;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sanadwich ELISA;Sensitivity: 3.9 pg/mL |
|||
NOD2 ELISA Kit (Human) (OKAN06319) |
|||
OKAN06319 | Aviva Systems Biology | 96 Wells | 950.4 EUR |
Description: Description of target: This gene is a member of the Nod1/Apaf-1 family and encodes a protein with two caspase recruitment (CARD) domains and six leucine-rich repeats (LRRs). The protein is primarily expressed in the peripheral blood leukocytes. It plays a role in the immune response to intracellular bacterial lipopolysaccharides (LPS) by recognizing the muramyl dipeptide (MDP) derived from them and activating the NFKB protein. Mutations in this gene have been associated with Crohn disease and Blau syndrome. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.055 ng/mL |
|||
NOD2 ELISA Kit (Human) (OKCA02128) |
|||
OKCA02128 | Aviva Systems Biology | 96 Wells | 999.6 EUR |
Description: Description of target: Involved in gastrointestinal immunity. Upon stimulation by muramyl dipeptide (MDP), a fragment of bacterial peptidoglycan, binds the proximal adapter receptor-interacting RIPK2, which recruits ubiquitin ligases as XIAP, BIRC2, BIRC3 and the LUBAC complex, triggering activation of MAP kinases and activation of NF-kappa-B signaling. This in turn leads to the transcriptional activation of hundreds of genes involved in immune response. Required for MDP-induced NLRP1-dependent CASP1 activation and IL1B release in macrophages.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 6.25 pg/mL |
|||
NOD2 ELISA Kit (Human) (OKCD02031) |
|||
OKCD02031 | Aviva Systems Biology | 96 Wells | 997.2 EUR |
Description: Description of target: Involved in gastrointestinal immunity. Upon stimulation by muramyl dipeptide (MDP), a fragment of bacterial peptidoglycan, binds the proximal adapter receptor-interacting RIPK2, which recruits ubiquitin ligases as XIAP, BIRC2, BIRC3 and the LUBAC complex, triggering activation of MAP kinases and activation of NF-kappa-B signaling. This in turn leads to the transcriptional activation of hundreds of genes involved in immune response. Required for MDP-induced NLRP1-dependent CASP1 activation and IL1B release in macrophages.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich Immunoassay;Sensitivity: < 0.055 ng/mL |
|||
Nod2 ORF Vector (Rat) (pORF) |
|||
ORF071395 | ABM | 1.0 ug DNA | 607.2 EUR |
NOD2 ORF Vector (Human) (pORF) |
|||
ORF026166 | ABM | 1.0 ug DNA | 486 EUR |
Nod2 ORF Vector (Mouse) (pORF) |
|||
ORF051499 | ABM | 1.0 ug DNA | 607.2 EUR |
h NOD2 inducible lentiviral particles |
|||
LVP627 | GenTarget | 1x107 IFU/ml x 200ul | 541.2 EUR |
Description: Pre-made over-expression lentivirus for expressing human target: NOD2 (nucleotide-binding oligomerization domain containing 2), [alternative names: ACUG; BLAU; CARD15; CD; CLR16.3; IBD1; NLRC2; NOD2B; PSORAS1]. The sub-cloned codon sequence is identical (100% match) to CDS region in NCBI ID: NM_022162.1. It also contains a RFP-Blasticidin dual selection marker. |
|||
pECMV-Nod2-m-FLAG Plasmid |
|||
PVT15371 | Lifescience Market | 2 ug | 390 EUR |
Anti-CARD15 / NOD2 (Internal) antibody |
|||
STJ70992 | St John's Laboratory | 100 µg | 430.8 EUR |
Polyclonal NOD2 / CARD15 Antibody (N-Terminus) |
|||
APR02524G | Leading Biology | 0.05mg | 580.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD2 / CARD15 (N-Terminus). This antibody is tested and proven to work in the following applications: |
|||
Polyclonal NOD2 / CARD15 Antibody (C-Terminus) |
|||
APR02525G | Leading Biology | 0.05mg | 580.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NOD2 / CARD15 (C-Terminus). This antibody is tested and proven to work in the following applications: |
|||
NOD2 sgRNA CRISPR Lentivector set (Human) |
|||
K1438601 | ABM | 3 x 1.0 ug | 406.8 EUR |
Nod2 sgRNA CRISPR Lentivector set (Mouse) |
|||
K4411601 | ABM | 3 x 1.0 ug | 406.8 EUR |
Nod2 sgRNA CRISPR Lentivector set (Rat) |
|||
K6718501 | ABM | 3 x 1.0 ug | 406.8 EUR |
Polyclonal Goat Anti-CARD15 / NOD2 (Internal) Antibody |
|||
APG00059G | Leading Biology | 0.1mg | 580.8 EUR |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-CARD15 / NOD2 (Internal) . This antibody is tested and proven to work in the following applications: |
|||
NOD2 Chemi-Luminescent ELISA Kit (Human) (OKCD03832) |
|||
OKCD03832 | Aviva Systems Biology | 96 Wells | 1185.6 EUR |
Description: Description of target: Involved in gastrointestinal immunity. Upon stimulation by muramyl dipeptide (MDP), a fragment of bacterial peptidoglycan, binds the proximal adapter receptor-interacting RIPK2, which recruits ubiquitin ligases as XIAP, BIRC2, BIRC3 and the LUBAC complex, triggering activation of MAP kinases and activation of NF-kappa-B signaling. This in turn leads to the transcriptional activation of hundreds of genes involved in immune response. Required for MDP-induced NLRP1-dependent CASP1 activation and IL1B release in macrophages .;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.0412 ng/mL |
|||
NOD2 sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
K1438602 | ABM | 1.0 ug DNA | 184.8 EUR |
NOD2 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
K1438603 | ABM | 1.0 ug DNA | 184.8 EUR |
NOD2 sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
K1438604 | ABM | 1.0 ug DNA | 184.8 EUR |
Nod2 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
K4411602 | ABM | 1.0 ug DNA | 184.8 EUR |
Nod2 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
K4411603 | ABM | 1.0 ug DNA | 184.8 EUR |
Nod2 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
K4411604 | ABM | 1.0 ug DNA | 184.8 EUR |
Nod2 sgRNA CRISPR Lentivector (Rat) (Target 1) |
|||
K6718502 | ABM | 1.0 ug DNA | 184.8 EUR |
Nod2 sgRNA CRISPR Lentivector (Rat) (Target 2) |
|||
K6718503 | ABM | 1.0 ug DNA | 184.8 EUR |
Nod2 sgRNA CRISPR Lentivector (Rat) (Target 3) |
|||
K6718504 | ABM | 1.0 ug DNA | 184.8 EUR |
NOD2 Protein Vector (Human) (pPB-C-His) |
|||
PV104662 | ABM | 500 ng | 973.2 EUR |
NOD2 Protein Vector (Human) (pPB-N-His) |
|||
PV104663 | ABM | 500 ng | 973.2 EUR |
NOD2 Protein Vector (Human) (pPM-C-HA) |
|||
PV104664 | ABM | 500 ng | 973.2 EUR |
NOD2 Protein Vector (Human) (pPM-C-His) |
|||
PV104665 | ABM | 500 ng | 973.2 EUR |
NOD2 Protein Vector (Rat) (pPB-C-His) |
|||
PV285578 | ABM | 500 ng | 1399.2 EUR |
NOD2 Protein Vector (Rat) (pPB-N-His) |
|||
PV285579 | ABM | 500 ng | 1399.2 EUR |
NOD2 Protein Vector (Rat) (pPM-C-HA) |
|||
PV285580 | ABM | 500 ng | 1399.2 EUR |
NOD2 Protein Vector (Rat) (pPM-C-His) |
|||
PV285581 | ABM | 500 ng | 1399.2 EUR |
NOD2 Protein Vector (Mouse) (pPB-C-His) |
|||
PV205994 | ABM | 500 ng | 1278 EUR |
NOD2 Protein Vector (Mouse) (pPB-N-His) |
|||
PV205995 | ABM | 500 ng | 1278 EUR |
NOD2 Protein Vector (Mouse) (pPM-C-HA) |
|||
PV205996 | ABM | 500 ng | 1278 EUR |
NOD2 Protein Vector (Mouse) (pPM-C-His) |
|||
PV205997 | ABM | 500 ng | 1278 EUR |
Nod2 3'UTR Luciferase Stable Cell Line |
|||
TU214065 | ABM | 1.0 ml | Ask for price |
Nod2 3'UTR GFP Stable Cell Line |
|||
TU264065 | ABM | 1.0 ml | Ask for price |
Nod2 3'UTR Luciferase Stable Cell Line |
|||
TU114191 | ABM | 1.0 ml | Ask for price |
Nod2 3'UTR GFP Stable Cell Line |
|||
TU164191 | ABM | 1.0 ml | Ask for price |
NOD2 3'UTR GFP Stable Cell Line |
|||
TU065801 | ABM | 1.0 ml | 1636.8 EUR |
NOD2 3'UTR Luciferase Stable Cell Line |
|||
TU015801 | ABM | 1.0 ml | 1636.8 EUR |
Nucleotide Binding Oligomerization Domain Containing 2 (NOD2) Antibody |
|||
20-abx114240 | Abbexa |
|
|
Nucleotide Binding Oligomerization Domain Containing 2 (NOD2) Antibody |
|||
20-abx302321 | Abbexa |
|
|
Nucleotide Binding Oligomerization Domain Containing 2 (NOD2) Antibody |
|||
abx235781-100ug | Abbexa | 100 ug | 661.2 EUR |
NOD2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV) |
|||
LV645601 | ABM | 1.0 ug DNA | 1626 EUR |
NOD2 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
LV645605 | ABM | 1.0 ug DNA | 1626 EUR |
NOD2 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
LV645606 | ABM | 1.0 ug DNA | 1626 EUR |
Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) Antibody |
|||
20-abx211027 | Abbexa |
|
|
Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) Antibody |
|||
20-abx339338 | Abbexa |
|
|
Nucleotide Binding Oligomerization Domain Containing 2 (NOD2) Antibody (HRP) |
|||
20-abx316579 | Abbexa |
|
|
Nucleotide Binding Oligomerization Domain Containing 2 (NOD2) Antibody (FITC) |
|||
20-abx316580 | Abbexa |
|
|
Nucleotide Binding Oligomerization Domain Containing 2 (NOD2) Antibody (Biotin) |
|||
20-abx316581 | Abbexa |
|
|
NOD2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
K1438605 | ABM | 3 x 1.0 ug | 451.2 EUR |
Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
|||
K4411605 | ABM | 3 x 1.0 ug | 451.2 EUR |
Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) |
|||
K6718505 | ABM | 3 x 1.0 ug | 451.2 EUR |
Human Nucleotide-binding oligomerization domain-containing protein 2(NOD2) ELISA kit |
|||
CSB-EL015915HU-24T | Cusabio | 1 plate of 24 wells | 198 EUR |
Description: Quantitativesandwich ELISA kit for measuring Human Nucleotide-binding oligomerization domain-containing protein 2 (NOD2) in samples from serum, plasma, asciticfluid, tissue homogenates, cell lysates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
|||
Human Nucleotide-binding oligomerization domain-containing protein 2(NOD2) ELISA kit |
|||
1-CSB-EL015915HU | Cusabio |
|
|
Description: Quantitativesandwich ELISA kit for measuring Human Nucleotide-binding oligomerization domain-containing protein 2(NOD2) in samples from serum, plasma, asciticfluid, tissue homogenates, cell lysates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
|||
Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) CLIA Kit |
|||
20-abx190892 | Abbexa |
|
|
Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) ELISA Kit |
|||
20-abx258642 | Abbexa |
|
|
NOD2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA) |
|||
LV645602 | ABM | 1.0 ug DNA | 1626 EUR |
NOD2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
|||
LV645603 | ABM | 1.0 ug DNA | 1695.6 EUR |
NOD2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
|||
LV645604 | ABM | 1.0 ug DNA | 1695.6 EUR |
NOD2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|||
K1438606 | ABM | 1.0 ug DNA | 200.4 EUR |
NOD2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|||
K1438607 | ABM | 1.0 ug DNA | 200.4 EUR |
NOD2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|||
K1438608 | ABM | 1.0 ug DNA | 200.4 EUR |
Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
|||
K4411606 | ABM | 1.0 ug DNA | 200.4 EUR |
Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
|||
K4411607 | ABM | 1.0 ug DNA | 200.4 EUR |
Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
|||
K4411608 | ABM | 1.0 ug DNA | 200.4 EUR |
Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1) |
|||
K6718506 | ABM | 1.0 ug DNA | 200.4 EUR |
Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2) |
|||
K6718507 | ABM | 1.0 ug DNA | 200.4 EUR |
Nod2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3) |
|||
K6718508 | ABM | 1.0 ug DNA | 200.4 EUR |
Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) ELISA Kit |
|||
SEK295Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | 5677.8 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in tissue homogenates, cell lysates and other biological fluids. |
|||
Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) ELISA Kit |
|||
SEK295Hu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | 572.76 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in tissue homogenates, cell lysates and other biological fluids. |
|||
Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) ELISA Kit |
|||
SEK295Hu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | 766.8 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in tissue homogenates, cell lysates and other biological fluids. |
|||
Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) ELISA Kit |
|||
SEK295Hu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | 3090.6 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in tissue homogenates, cell lysates and other biological fluids. |
|||
Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) ELISA Kit |
|||
4-SEK295Hu | Cloud-Clone |
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in samples from tissue homogenates, cell lysates and other biological fluids with no significant corss-reactivity with analogues from other species. |
|||
Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2)CLIA Kit |
|||
SCK295Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | 6777.36 EUR |
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in Tissue homogenates, cell lysates and other biological fluids. |
|||
Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2)CLIA Kit |
|||
SCK295Hu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | 663.31 EUR |
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in Tissue homogenates, cell lysates and other biological fluids. |
|||
Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2)CLIA Kit |
|||
SCK295Hu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | 896.16 EUR |
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in Tissue homogenates, cell lysates and other biological fluids. |
|||
Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2)CLIA Kit |
|||
SCK295Hu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | 3672.72 EUR |
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) in Tissue homogenates, cell lysates and other biological fluids. |
|||
Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2) CLIA Kit |
|||
4-SCK295Hu | Cloud-Clone |
|
|
Description: Double-antibody Sandwich chemiluminescent immunoassay for detection of Human Nucleotide Binding Oligomerization Domain Containing Protein 2 (NOD2)Tissue homogenates, cell lysates and other biological fluids |
|||
Human Nucleotide Binding Oligomerization Domain Containing Protein 2 ELISA Kit (NOD2) |
|||
RK01942 | Abclonal | 96 Tests | 625.2 EUR |
ELISA kit for Human NOD2 (Nucleotide Binding Oligomerization Domain Containing Protein 2) |
|||
ELK5352 | ELK Biotech | 1 plate of 96 wells | 518.4 EUR |
Description: A sandwich ELISA kit for detection of Nucleotide Binding Oligomerization Domain Containing Protein 2 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
Data evaluation was performed utilizing Statistical Package for Social Sciences model 20.Left aspect predominated with 88 (63.7%) and extension kind was frequent in 135 (97.8%). Thirteen (9.4%) sufferers had been initially managed by conventional bonesetters. A complete of 138 kids underwent operative fixation with imply age of seven.47 years and gender ratio of two:1 boy to woman.
Fall from cliff, ladders and rooftops had been the prevailing explanation for harm 73 (52.8%). Average time between harm and surgical procedure was 5.2 days. Closed discount was performed in 100 (72.4%) sufferers whereas open discount was crucial in 38 (27.5%) sufferers.Closed extension kind pediatric supracondylar fracture was frequent in this examine. Fall from cliff, rooftop and ladder are the most important explanation for fracture. Delayed presentation and preliminary administration of the fracture by the standard bonesetters makes supracondylar fracture tougher in useful resource restricted setting like ours.